New Drug Review: Retevmo

Inbox

x

MPR First Look <editor@email.empr.com> Unsubscribe

7:21 PM (2 hours ago)

to me

If you are having trouble viewing this email, click here.

NEW DRUG PRODUCT: RETEVMO FEATURED Find out more about Retevmo including dosing and important safety information with our slideshow, complete drug monograph, and downloadable PDF. DRUGS IN THE PIPELINE Setmelanotide Granted Priority Review for Rare Genetic Obesity Disorders Dasotraline Development for ADHD, Binge Eating Disorder Halted, NDAs Withdrawn Elafibranor Effect Not Significantly Different From Placebo in NASH Study Varenicline Nasal Spray Improves Signs, Symptoms of Dry Eye Disease in Trial Sutimlimab Under Review for Hemolysis in Cold Agglutinin Disease The right dose of information. eMPR.com CME/CE Spotlight Dispelling the Myths of Influenza Management AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), CE for Pharmacists CLICK HERE FOR A FULL LIST OF COURSES CE/CME Powered By myCME